Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -5.739M
March 31, 2026 -0.782M
December 31, 2025 -4.41M
September 30, 2025 -3.35M
June 30, 2025 -31.72M
March 31, 2025 -82.38M
December 31, 2024 -137.79M
September 30, 2024 -197.78M
June 30, 2024 -211.23M
March 31, 2024 -202.38M
December 31, 2023 -165.46M
September 30, 2023 -135.47M
June 30, 2023 -127.13M
March 31, 2023 -130.44M
December 31, 2022 -133.41M
September 30, 2022 -144.64M
June 30, 2022 -150.70M
March 31, 2022 -146.28M
December 31, 2021 -141.98M
September 30, 2021 -125.27M
June 30, 2021 -104.31M
March 31, 2021 -84.43M
December 31, 2020 -70.30M
September 30, 2020 -64.21M
June 30, 2020 -64.92M
Date Value
March 31, 2020 -56.82M
December 31, 2019 -46.15M
September 30, 2019 -47.20M
June 30, 2019 -39.78M
March 31, 2019 -35.82M
December 31, 2018 -32.52M
September 30, 2018 -20.84M
June 30, 2018 -15.60M
March 31, 2018 -14.01M
December 31, 2017 -16.32M
September 30, 2017 -26.74M
June 30, 2017 -35.21M
March 31, 2017 -26.66M
December 31, 2016 -21.21M
September 30, 2016 -9.818M
June 30, 2016 1.716M
March 31, 2016 -2.314M
December 31, 2015 -6.523M
September 30, 2015 -12.01M
June 30, 2015 -9.705M
March 31, 2015 -37.93M
December 31, 2014 -31.57M
September 30, 2014 -28.27M
June 30, 2014 -29.52M
March 31, 2014 -4.615M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Artivion, Inc. -9.157M
Glaukos Corp. -28.80M
TransMedics Group, Inc. 79.04M
Abbott Laboratories 7.824B
AngioDynamics, Inc. -3.873M